Verrica Pharmaceuticals Inc

1NE

Company Profile

  • Business description

    Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

  • Contact

    44 West Gay Street
    Suite 400
    West ChesterPA19380
    USA

    T: +1 484 453-3300

    E: [email protected]

    https://www.verrica.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    71

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,203.9028.800.35%
CAC 407,570.5134.250.45%
DAX 4022,256.7914.340.06%
Dow JONES (US)40,093.3820.12-0.05%
FTSE 1008,422.046.790.08%
HKSE21,971.968.78-0.04%
NASDAQ17,206.66176.28-1.01%
Nikkei 22535,839.99134.250.38%
NZX 50 Index12,098.8981.050.67%
S&P 5005,495.7029.51-0.53%
S&P/ASX 2007,997.1028.900.36%
SSE Composite Index3,288.416.65-0.20%

Market Movers